Browsing by Author Sumitra Thongprasert

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 33  next >
Issue DateTitleAuthor(s)
20-Jul-2011Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)Masahiro Fukuoka; Yi Long Wu; Sumitra Thongprasert; Patrapim Sunpaweravong; Swan Swan Leong; Virote Sriuranpong; Tsu Yi Chao; Kazuhiko Nakagawa; Da Tong Chu; Nagahiro Saijo
1-Jul-2019Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?Alexandru Eniu; Nathan I. Cherny; Melanie Bertram; Sumitra Thongprasert; Jean Yves Douillard; Gracemarie Bricalli; Malvika Vyas; Dario Trapani
1-Jan-2011Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approachManuel Salto-Tellez; Ming Sound Tsao; Jin Yuan Shih; Sumitra Thongprasert; Shun Lu; Gee Chen Chang; Joseph Siu Kie Au; Teh Ying Chou; Jong Seok Lee; Yuan Kai Shi; Ahmad Radzi; Jin Hyoung Kang; Sang We Kim; Soo Yong Tan; James Chih Hsin Yang
1-Dec-2011Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancerSumitra Thongprasert; Unchalee Permsuwan; Chidchanok Ruengorn; Chaiyut Charoentum; Busyamas Chewaskulyong
4-May-2017Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in ThailandSumitra Thongprasert; Unchalee Permsuwan
15-Jul-2015Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapyTony Mok; Yi Long Wu; Jin Soo Lee; Chong Jen Yu; Virote Sriuranpong; Jennifer Sandoval-Tan; Guia Ladrera; Sumitra Thongprasert; Vichien Srimuninnimit; Meilin Liao; Yunzhong Zhu; Caicun Zhou; Fatima Fuerte; Benjamin Margono; Wei Wen; Julie Tsai; Matt Truman; Barbara Klughammer; David S. Shames; Lin Wu
24-Sep-2009Editorial: Update on Anti-EGFR therapyDaniel Chua; Peter Fasching; Brigette Ma; Sumitra Thongprasert; Lori Wirth
1-Feb-2017Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLCYi Long Wu; Nagahiro Saijo; Sumitra Thongprasert; J. C.H. Yang; Baohui Han; Benjamin Margono; Busayamas Chewaskulyong; Patrapim Sunpaweravong; Yuichiro Ohe; Yukito Ichinose; Jin Ji Yang; Tony S.K. Mok; Helen Young; Vincent Haddad; Yuri Rukazenkov; Masahiro Fukuoka
1-Jan-2017Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE studyKeunchil Park; Eun Kyung Cho; Maximino Bello; Myung Ju Ahn; Sumitra Thongprasert; Eun Kee Song; Victoria Soldatenkova; Henrik Depenbrock; Tarun Puri; Mauro Orlando
1-Jun-2011Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trialTony S K Mok; Te Chun Hsia; Chun Ming Tsai; Kenneth Tsang; Gee Chen Chang; John Wen Cheng Chang; Sirisinha Thitiya; Virote Sriuranpong; Sumitra Thongprasert; Daniel Tt Chua; Nicola Moore; Christian Manegold
1-Jan-2014Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysisUnchalee Permsuwan; Narawadee Niamhun; Narumon Tanatip; Sumitra Thongprasert
14-Jul-2005Erlotinib in previously treated non-small-cell lung cancerFrances A. Shepherd; José Rodrigues Pereira; Tudor Ciuleanu; Huat Tan Eng; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; M. Van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
28-May-2007Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinomaChalyut Charoentum; Sumitra Thongprasert; Busyamas Chewaskulyong; Sutthirak Munprakan
3-Sep-2009Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaTony S. Mok; Yi Long Wu; Sumitra Thongprasert; Chih Hsin Yang; Da Tong Chu; Nagahiro Saijo; Patrapim Sunpaweravong; Baohui Han; Benjamin Margono; Yukito Ichinose; Yutaka Nishiwaki; Yuichiro Ohe; Jin Ji Yang; Busyamas Chewaskulyong; Haiyi Jiang; Emma L. Duffield; Claire L. Watkins; Alison A. Armour; Masahiro Fukuoka
1-Jun-2017Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall SurvivalChee Khoon Lee; Lucy Davies; Yi Long Wu; Tetsuya Mitsudomi; Akira Inoue; Rafael Rosell; Caicun Zhou; Kazuhiko Nakagawa; Sumitra Thongprasert; Masahiro Fukuoka; Sally Lord; Ian Marschner; Yu Kang Tu; Richard J. Gralla; Val Gebski; Tony Mok; James Chih Hsin Yang
1-Jan-2011Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)Sumitra Thongprasert; Emma Duffield; Nagahiro Saijo; Yi Long Wu; James Chih Hsin Yang; Da Tong Chu; Meilin Liao; Yuh Min Chen; Han Pin Kuo; Shunichi Negoro; Kwok Chi Lam; Alison Armour; Patrick Magill; Masahiro Fukuoka
1-May-2013Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysisChee Khoon Lee; Chris Brown; Richard J. Gralla; Vera Hirsh; Sumitra Thongprasert; Chun Ming Tsai; Eng Huat Tan; James Chung Man Ho; Da Tong Chu; Adel Zaatar; Jemela Anne Osorio Sanchez; Vu Van Vu; Joseph Siu Kie Au; Akira Inoue; Siow Ming Lee; Val Gebski; James Chih Hsin Yang
1-Jun-2011An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East AsiaJohn Wen Cheng Chang; Sumitra Thongprasert; Elaine Wright; Kenneth Tsang; Heung Tae Kim; Myung Ju Ahn; Joo Hang Kim; Jin Hyoung Kang; Sang We Kim; Stefan Walzer
1-Sep-2005Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groupsAthavudh Deesomchok; Namporn Dechayonbancha; Sumitra Thongprasert
1-Sep-2010Lung cancer working group reportNagahiro Saijo; Masahiro Fukuoka; Sumitra Thongprasert; Yukito Ichinose; Tetsuya Mitsudomi; Tony Shu Kam Mok; Yuichiro Ohe; Keunchil Park; Yi Long Wu